{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:40:58Z","timestamp":1787002858829,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Aortic intramural hematoma (IMH) can evolve toward reabsorption, dissection or aneurysm. Hypertension is the most common predisposing factor in IMH and aneurysm patients, and the hypertensive mediator angiotensin-II induces both in mice. We have previously shown that constitutive deletion of\n                    <jats:italic>Rcan1<\/jats:italic>\n                    isoforms prevents Angiotensin II-induced aneurysm in mice. Here we generate mice conditionally lacking each isoform or all isoforms in vascular smooth muscle cells, endothelial cells, or ubiquitously, to determine the contribution to aneurysm development of\n                    <jats:italic>Rcan1<\/jats:italic>\n                    isoforms in vascular cells. Surprisingly, conditional\n                    <jats:italic>Rcan1<\/jats:italic>\n                    deletion in either vascular cell-type induces a hypercontractile phenotype and aortic medial layer disorganization, predisposing to hypertension-mediated aortic rupture, IMH, and aneurysm. These processes are blocked by ROCK inhibition. We find that Rcan1 associates with GSK-3\u03b2, whose inhibition decreases myosin activation. Our results identify potential therapeutic targets for intervention in IMH and aneurysm and call for caution when interpreting phenotypes of constitutively and inducibly deficient mice.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-07071-7","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T05:40:16Z","timestamp":1541742016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture"],"prefix":"10.1038","volume":"9","author":[{"given":"Silvia","family":"Villahoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Sof\u00eda","family":"Yunes-Leites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"M\u00e9ndez-Barbero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Urso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0852-7520","authenticated-orcid":false,"given":"Elena","family":"Bonzon-Kulichenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagrario","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4152-7621","authenticated-orcid":false,"given":"J. Francisco","family":"Nistal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-5092","authenticated-orcid":false,"given":"Jesus","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Offermanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5779-9122","authenticated-orcid":false,"given":"Juan Miguel","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1410-8621","authenticated-orcid":false,"given":"Miguel R.","family":"Campanero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"7071_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/01.CIR.0000081776.49923.5A","volume":"108","author":"A Evangelista","year":"2003","unstructured":"Evangelista, A. et al. Long-term follow-up of aortic intramural hematoma: predictors of outcome. Circulation 108, 583\u2013589 (2003).","journal-title":"Circulation"},{"key":"7071_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/CIRCULATIONAHA.113.001809","volume":"129","author":"IB Alomari","year":"2014","unstructured":"Alomari, I. B. et al. Aortic intramural hematoma and its complications. Circulation 129, 711\u2013716 (2014).","journal-title":"Circulation"},{"key":"7071_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/hrt.2003.027649","volume":"90","author":"A Evangelista","year":"2004","unstructured":"Evangelista, A. Aortic intramural haematoma: remarks and conclusions. Heart 90, 379\u2013380 (2004).","journal-title":"Heart"},{"key":"7071_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jjcc.2014.05.005","volume":"64","author":"JK Song","year":"2014","unstructured":"Song, J. K. Update in acute aortic syndrome: intramural hematoma and incomplete dissection as new disease entities. J. Cardiol. 64, 153\u2013161 (2014).","journal-title":"J. Cardiol."},{"key":"7071_CR5","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/CIRCRESAHA.114.304936","volume":"116","author":"JD Humphrey","year":"2015","unstructured":"Humphrey, J. D., Schwartz, M. A., Tellides, G. & Milewicz, D. M. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. Circ. Res. 116, 1448\u20131461 (2015).","journal-title":"Circ. Res."},{"key":"7071_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-med-100415-022956","volume":"68","author":"DM Milewicz","year":"2017","unstructured":"Milewicz, D. M., Prakash, S. K. & Ramirez, F. Therapeutics targeting drivers of thoracic aortic aneurysms and acute aortic dissections: insights from predisposing genes and mouse models. Annu. Rev. Med. 68, 51\u201367 (2017).","journal-title":"Annu. Rev. Med."},{"key":"7071_CR7","doi-asserted-by":"publisher","first-page":"16053","DOI":"10.1038\/nrdp.2016.53","volume":"2","author":"CA Nienaber","year":"2016","unstructured":"Nienaber, C. A. et al. Aortic dissection. Nat. Rev. Dis. Prim. 2, 16053 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"7071_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jama.283.7.897","volume":"283","author":"PG Hagan","year":"2000","unstructured":"Hagan, P. G. et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 283, 897\u2013903 (2000).","journal-title":"JAMA"},{"key":"7071_CR9","doi-asserted-by":"publisher","first-page":"e001513","DOI":"10.1161\/JAHA.114.001513","volume":"4","author":"M Landenhed","year":"2015","unstructured":"Landenhed, M. et al. Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: a prospective cohort study. J. Am. Heart Assoc. 4, e001513 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"7071_CR10","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1016\/j.ajpath.2014.05.014","volume":"184","author":"DL Rateri","year":"2014","unstructured":"Rateri, D. L. et al. Angiotensin II induces region-specific medial disruption during evolution of ascending aortic aneurysms. Am. J. Pathol. 184, 2586\u20132595 (2014).","journal-title":"Am. J. Pathol."},{"key":"7071_CR11","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1172\/JCI7818","volume":"105","author":"A Daugherty","year":"2000","unstructured":"Daugherty, A., Manning, M. W. & Cassis, L. A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105, 1605\u20131612 (2000).","journal-title":"J. Clin. Invest."},{"key":"7071_CR12","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1161\/HYPERTENSIONAHA.109.140558","volume":"55","author":"Y Kanematsu","year":"2010","unstructured":"Kanematsu, Y. et al. Pharmacologically induced thoracic and abdominal aortic aneurysms in mice. Hypertension 55, 1267\u20131274 (2010).","journal-title":"Hypertension"},{"key":"7071_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMcibr0905244","volume":"361","author":"NL Weintraub","year":"2009","unstructured":"Weintraub, N. L. Understanding abdominal aortic aneurysm. N. Engl. J. Med. 361, 1114\u20131116 (2009).","journal-title":"N. Engl. J. Med."},{"key":"7071_CR14","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1084\/jem.20110503","volume":"208","author":"V Esteban","year":"2011","unstructured":"Esteban, V. et al. Regulator of calcineurin 1 mediates pathological vascular wall remodeling. J. Exp. Med. 208, 2125\u20132139 (2011).","journal-title":"J. Exp. Med."},{"key":"7071_CR15","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1096\/fj.06-7246com","volume":"21","author":"KJ Davies","year":"2007","unstructured":"Davies, K. J. et al. Renaming the DSCR1\/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J. 21, 3023\u20133028 (2007).","journal-title":"FASEB J."},{"key":"7071_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1006\/geno.1997.4866","volume":"44","author":"JJ Fuentes","year":"1997","unstructured":"Fuentes, J. J., Pritchard, M. A. & Estivill, X. Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 44, 358\u2013361 (1997).","journal-title":"Genomics"},{"key":"7071_CR17","doi-asserted-by":"publisher","first-page":"29435","DOI":"10.1074\/jbc.M506205200","volume":"280","author":"E Cano","year":"2005","unstructured":"Cano, E., Canellada, A., Minami, T., Iglesias, T. & Redondo, J. M. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin\/nuclear factor of activated T cells-dependent pathway. J. Biol. Chem. 280, 29435\u201329443 (2005).","journal-title":"J. Biol. Chem."},{"key":"7071_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1006\/abbi.1997.0109","volume":"342","author":"DR Crawford","year":"1997","unstructured":"Crawford, D. R. et al. Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress. Arch. Biochem. Biophys. 342, 6\u201312 (1997).","journal-title":"Arch. Biochem. Biophys."},{"key":"7071_CR19","first-page":"509","volume-title":"Drugs Today (Barc)","author":"G Ermak","year":"2002","unstructured":"Ermak, G. & Davies, K. J. Gene expression in Alzheimer\u2019s disease. Drugs Today (Barc.) 38, 509\u2013516 (2002)."},{"key":"7071_CR20","doi-asserted-by":"publisher","first-page":"50537","DOI":"10.1074\/jbc.M406454200","volume":"279","author":"T Minami","year":"2004","unstructured":"Minami, T. et al. Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J. Biol. Chem. 279, 50537\u201350554 (2004).","journal-title":"J. Biol. Chem."},{"key":"7071_CR21","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1128\/MCB.00494-15","volume":"35","author":"J Oller","year":"2015","unstructured":"Oller, J. et al. C\/EBPbeta and nuclear factor of activated T cells differentially regulate Adamts-1 induction by stimuli associated with vascular remodeling. Mol. Cell. Biol. 35, 3409\u20133422 (2015).","journal-title":"Mol. Cell. Biol."},{"key":"7071_CR22","doi-asserted-by":"publisher","first-page":"H533","DOI":"10.1152\/ajpheart.00002.2002","volume":"283","author":"Y Wang","year":"2002","unstructured":"Wang, Y. et al. Direct biomechanical induction of endogenous calcineurin inhibitor Down syndrome critical region-1 in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 283, H533\u2013H539 (2002).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"7071_CR23","doi-asserted-by":"publisher","first-page":"E61","DOI":"10.1161\/01.RES.87.12.e61","volume":"87","author":"J Yang","year":"2000","unstructured":"Yang, J. et al. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ. Res. 87, E61\u2013E68 (2000).","journal-title":"Circ. Res."},{"key":"7071_CR24","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/nature08062","volume":"459","author":"KH Baek","year":"2009","unstructured":"Baek, K. H. et al. Down\u2019s syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459, 1126\u20131130 (2009).","journal-title":"Nature"},{"key":"7071_CR25","doi-asserted-by":"publisher","first-page":"13161","DOI":"10.1523\/JNEUROSCI.3974-07.2007","volume":"27","author":"CA Hoeffer","year":"2007","unstructured":"Hoeffer, C. A. et al. The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. J. Neurosci. 27, 13161\u201313172 (2007).","journal-title":"J. Neurosci."},{"key":"7071_CR26","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/emmm.201302842","volume":"5","author":"N Mendez-Barbero","year":"2013","unstructured":"Mendez-Barbero, N. et al. A major role for RCAN1 in atherosclerosis progression. EMBO Mol. Med. 5, 1901\u20131917 (2013).","journal-title":"EMBO Mol. Med."},{"key":"7071_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ccr.2008.02.018","volume":"13","author":"S Ryeom","year":"2008","unstructured":"Ryeom, S. et al. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell. 13, 420\u2013431 (2008).","journal-title":"Cancer Cell."},{"key":"7071_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.20081140","volume":"206","author":"YJ Yang","year":"2009","unstructured":"Yang, Y. J. et al. Rcan1 negatively regulates Fc epsilonRI-mediated signaling and mast cell function. J. Exp. Med. 206, 195\u2013207 (2009).","journal-title":"J. Exp. Med."},{"key":"7071_CR29","doi-asserted-by":"publisher","first-page":"8719","DOI":"10.1074\/jbc.275.12.8719","volume":"275","author":"B Rothermel","year":"2000","unstructured":"Rothermel, B. et al. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J. Biol. Chem. 275, 8719\u20138725 (2000).","journal-title":"J. Biol. Chem."},{"key":"7071_CR30","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1101\/gad.14.13.1595","volume":"14","author":"TJ Kingsbury","year":"2000","unstructured":"Kingsbury, T. J. & Cunningham, K. W. A conserved family of calcineurin regulators. Genes Dev. 14, 1595\u20131604 (2000).","journal-title":"Genes Dev."},{"key":"7071_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1073\/pnas.0237225100","volume":"100","author":"RB Vega","year":"2003","unstructured":"Vega, R. B. et al. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc. Natl Acad. Sci. USA 100, 669\u2013674 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7071_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09002","volume":"465","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483\u2013486 (2010).","journal-title":"Nature"},{"key":"7071_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nm1666","volume":"14","author":"A Wirth","year":"2008","unstructured":"Wirth, A. et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat. Med. 14, 64\u201368 (2008).","journal-title":"Nat. Med."},{"key":"7071_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.stem.2007.03.002","volume":"1","author":"Y Ruzankina","year":"2007","unstructured":"Ruzankina, Y. et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell. Stem. Cell. 1, 113\u2013126 (2007).","journal-title":"Cell. Stem. Cell."},{"key":"7071_CR35","doi-asserted-by":"publisher","first-page":"H253","DOI":"10.1152\/ajpheart.00786.2010","volume":"301","author":"ME Hall","year":"2011","unstructured":"Hall, M. E., Smith, G., Hall, J. E. & Stec, D. E. Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 301, H253\u2013H260 (2011).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"7071_CR36","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1161\/CIRCRESAHA.117.311522","volume":"122","author":"V Parra","year":"2018","unstructured":"Parra, V. et al. Down syndrome critical region 1 Gene, Rcan1, helps maintain a more fused mitochondrial network. Circ. Res. 122, e20\u2013e33 (2018).","journal-title":"Circ. Res."},{"key":"7071_CR37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/CIRCRESAHA.115.307495","volume":"118","author":"H Nakayama","year":"2016","unstructured":"Nakayama, H., Nishida, K. & Otsu, K. Macromolecular degradation systems and cardiovascular aging. Circ. Res. 118, 1577\u20131592 (2016).","journal-title":"Circ. Res."},{"key":"7071_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coph.2017.12.002","volume":"40","author":"WSD Tan","year":"2018","unstructured":"Tan, W. S. D., Liao, W., Zhou, S., Mei, D. & Wong, W. F. Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases. Curr. Opin. Pharmacol. 40, 9\u201317 (2018).","journal-title":"Curr. Opin. Pharmacol."},{"key":"7071_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejphar.2015.03.090","volume":"763","author":"BS van Thiel","year":"2015","unstructured":"van Thiel, B. S., van der Pluijm, I., te Riet, L., Essers, J. & Danser, A. H. The renin-angiotensin system and its involvement in vascular disease. Eur. J. Pharmacol. 763, 3\u201314 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"7071_CR40","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/00005344-198812007-00006","volume":"12 Suppl 7","author":"S Julius","year":"1988","unstructured":"Julius, S. Amlodipine in hypertension: an overview of the clinical dossier. J. Cardiovasc. Pharmacol. 12 Suppl 7, S27\u2013S33 (1988).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"7071_CR41","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1139\/y94-200","volume":"72","author":"Y Zhang","year":"1994","unstructured":"Zhang, Y., Moreland, S. & Moreland, R. S. Regulation of vascular smooth muscle contraction: myosin light chain phosphorylation dependent and independent pathways. Can. J. Physiol. Pharmacol. 72, 1386\u20131391 (1994).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"7071_CR42","doi-asserted-by":"publisher","first-page":"e39269","DOI":"10.1371\/journal.pone.0039269","volume":"7","author":"T Kaneko-Kawano","year":"2012","unstructured":"Kaneko-Kawano, T. et al. Dynamic regulation of myosin light chain phosphorylation by Rho-kinase. PLoS ONE 7, e39269 (2012).","journal-title":"PLoS One"},{"key":"7071_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/FJC.0b013e318070d1bd","volume":"50","author":"JK Liao","year":"2007","unstructured":"Liao, J. K., Seto, M. & Noma, K. Rho kinase (ROCK) inhibitors. J. Cardiovasc. Pharmacol. 50, 17\u201324 (2007).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"7071_CR44","doi-asserted-by":"publisher","first-page":"20978","DOI":"10.1074\/jbc.M802588200","volume":"283","author":"W Jiang","year":"2008","unstructured":"Jiang, W. et al. p190A RhoGAP is a glycogen synthase kinase-3-beta substrate required for polarized cell migration. J. Biol. Chem. 283, 20978\u201320988 (2008).","journal-title":"J. Biol. Chem."},{"key":"7071_CR45","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1440-169X.2009.01141.x","volume":"51","author":"T Sun","year":"2009","unstructured":"Sun, T., Rodriguez, M. & Kim, L. Glycogen synthase kinase 3 in the world of cell migration. Dev. Growth Differ. 51, 735\u2013742 (2009).","journal-title":"Dev. Growth Differ."},{"key":"7071_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/leu.2013.184","volume":"28","author":"JA McCubrey","year":"2014","unstructured":"McCubrey, J. A. et al. Multifaceted roles of GSK-3 and Wnt\/beta-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia 28, 15\u201333 (2014).","journal-title":"Leukemia"},{"key":"7071_CR47","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1111\/bph.13922","volume":"174","author":"EC van Kappel","year":"2017","unstructured":"van Kappel, E. C. & Maurice, M. M. Molecular regulation and pharmacological targeting of the beta-catenin destruction complex. Br. J. Pharmacol. 174, 4575\u20134588 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"7071_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnmol.2012.00014","volume":"5","author":"L Freland","year":"2012","unstructured":"Freland, L. & Beaulieu, J. M. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front. Mol. Neurosci. 5, 14 (2012).","journal-title":"Front. Mol. Neurosci."},{"key":"7071_CR49","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1021\/jm034108b","volume":"46","author":"S Conde","year":"2003","unstructured":"Conde, S., Perez, D. I., Martinez, A., Perez, C. & Moreno, F. J. Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching. J. Med. Chem. 46, 4631\u20134633 (2003).","journal-title":"J. Med. Chem."},{"key":"7071_CR50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/01.ATV.0000196565.38679.6d","volume":"26","author":"AC Langheinrich","year":"2006","unstructured":"Langheinrich, A. C. et al. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-\/-)\/low-density lipoprotein(-\/-) double knockout mice. Arterioscler. Thromb. Vasc. Biol. 26, 347\u2013352 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"7071_CR51","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3389\/fimmu.2017.01323","volume":"8","author":"C Ballesteros-Martinez","year":"2017","unstructured":"Ballesteros-Martinez, C. et al. Endothelial regulator of calcineurin 1 promotes barrier integrity and modulates histamine-induced barrier dysfunction in anaphylaxis. Front. Immunol. 8, 1323 (2017).","journal-title":"Front. Immunol."},{"key":"7071_CR52","doi-asserted-by":"publisher","first-page":"H1660","DOI":"10.1152\/ajpheart.00028.2009","volume":"296","author":"LA Cassis","year":"2009","unstructured":"Cassis, L. A. et al. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am. J. Physiol. Heart Circ. Physiol. 296, H1660\u2013H1665 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"7071_CR53","first-page":"2731","volume-title":"Sensors (Basel)","author":"JR Burgoyne","year":"2010","unstructured":"Burgoyne, J. R. & Eaton, P. Oxidant sensing by protein kinases a and g enables integration of cell redox state with phosphoregulation. Sensors (Basel) 10, 2731\u20132751 (2010)."},{"key":"7071_CR54","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/cam4.1019","volume":"6","author":"SK Dasgupta","year":"2017","unstructured":"Dasgupta, S. K., Le, A., Vijayan, K. V. & Thiagarajan, P. Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway. Cancer Med. 6, 809\u2013818 (2017).","journal-title":"Cancer Med."},{"key":"7071_CR55","doi-asserted-by":"publisher","first-page":"40401","DOI":"10.1074\/jbc.M111.253971","volume":"286","author":"MS Jung","year":"2011","unstructured":"Jung, M. S. et al. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation. J. Biol. Chem. 286, 40401\u201340412 (2011).","journal-title":"J. Biol. Chem."},{"key":"7071_CR56","doi-asserted-by":"publisher","first-page":"30401","DOI":"10.1074\/jbc.M200123200","volume":"277","author":"RB Vega","year":"2002","unstructured":"Vega, R. B., Yang, J., Rothermel, B. A., Bassel-Duby, R. & Williams, R. S. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J. Biol. Chem. 277, 30401\u201330407 (2002).","journal-title":"J. Biol. Chem."},{"key":"7071_CR57","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3389\/fphys.2016.00593","volume":"7","author":"B Bosche","year":"2016","unstructured":"Bosche, B. et al. Low-dose lithium stabilizes human endothelial barrier by decreasing MLC phosphorylation and universally augments cholinergic vasorelaxation capacity in a direct manner. Front. Physiol. 7, 593 (2016).","journal-title":"Front. Physiol."},{"key":"7071_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1399-5618.2009.00706.x","volume":"11 Suppl 2","author":"E Shorter","year":"2009","unstructured":"Shorter, E. The history of lithium therapy. Bipolar Disord. 11 Suppl 2, 4\u20139 (2009).","journal-title":"Bipolar Disord."},{"key":"7071_CR59","doi-asserted-by":"publisher","first-page":"571","DOI":"10.7150\/thno.14334","volume":"6","author":"MK Pandey","year":"2016","unstructured":"Pandey, M. K. & DeGrado, T. R. Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging. Theranostics 6, 571\u2013593 (2016).","journal-title":"Theranostics"},{"key":"7071_CR60","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/bdi.12336","volume":"17","author":"CC Lan","year":"2015","unstructured":"Lan, C. C. et al. A reduced risk of stroke with lithium exposure in bipolar disorder: a population-based retrospective cohort study. Bipolar Disord. 17, 705\u2013714 (2015).","journal-title":"Bipolar Disord."},{"key":"7071_CR61","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/hmg\/ddm049","volume":"16","author":"S Porta","year":"2007","unstructured":"Porta, S. et al. RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration. Hum. Mol. Genet. 16, 1039\u20131050 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"7071_CR62","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/embj.201386369","volume":"33","author":"A Escolano","year":"2014","unstructured":"Escolano, A. et al. Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38. EMBO J. 33, 1117\u20131133 (2014).","journal-title":"EMBO J."},{"key":"7071_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri, C. et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980 (2013).","journal-title":"Nat. Commun."},{"key":"7071_CR64","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1074\/mcp.M700239-MCP200","volume":"7","author":"S Martinez-Bartolome","year":"2008","unstructured":"Martinez-Bartolome, S. et al. Properties of average score distributions of SEQUEST: the probability ratio method. Mol. Cell. Proteom. 7, 1135\u20131145 (2008).","journal-title":"Mol. Cell. Proteom."},{"key":"7071_CR65","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1021\/pr5007284","volume":"14","author":"E Bonzon-Kulichenko","year":"2015","unstructured":"Bonzon-Kulichenko, E., Garcia-Marques, F., Trevisan-Herraz, M. & Vazquez, J. Revisiting peptide identification by high-accuracy mass spectrometry: problems associated with the use of narrow mass precursor windows. J. Proteome Res. 14, 700\u2013710 (2015).","journal-title":"J. Proteome Res."},{"key":"7071_CR66","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1021\/pr800362h","volume":"8","author":"P Navarro","year":"2009","unstructured":"Navarro, P. & Vazquez, J. A refined method to calculate false discovery rates for peptide identification using decoy databases. J. Proteome Res. 8, 1792\u20131796 (2009).","journal-title":"J. Proteome Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07071-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07071-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07071-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T15:12:03Z","timestamp":1671549123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07071-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["7071"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-07071-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4795"}}